-
2023-504962-52-00
5
2024-07-10
Triple negative breast cancer.
-
2023-508147-43-00
6
2024-05-31
Venous thromboembolism (in surgical patients)
-
2023-506150-21-00
4
2024-05-29
Celiac Disease
-
2023-507871-23-00
5
2024-05-27
Relapsed/Refractory Multiple Myeloma
-
2023-503219-14-01
10
2024-05-22
systemic sclerosis associated interstitial lung disease
-
2023-503631-18-01
5
2024-05-20
Nervous system diseases
-
2023-504899-25-00
5
2024-04-04
Metastatic castration resistant prostate cancer
-
2023-504923-20-00
5
2024-04-04
Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer
-
2022-500531-36-00
4
2024-02-02
Type 1 diabetes mellitus
-
2023-503327-26-00
5
2024-01-31
Sjogren's syndrome
-
2023-509142-35-00
6
2024-01-29
Atrial fibrillation after stress (e.g., noncardiac surgery or acute me
-
2023-506971-89-00
5
2024-01-25
Coronary Artery Disease
-
2022-503061-29-00
7
2024-01-22
Neoplasms benign malignant and unspecified (incl cysts and polyps). Me
-
2023-504340-34-01
6
2024-01-11
Coronary artery disease
-
2022-502046-28-00
5
2023-12-22
HER2-Positive, PIK3CA Mutated, Locally Advanced or Metastatic Breast C
-
2022-501941-63-00
7
2023-12-13
Multiple myeloma
-
2023-503224-66-00
5
2023-10-31
Atrial Fibrillation
-
2023-504999-25-00
5
2023-07-14
Acute Myeloid Leukemia
-
2022-500967-11-00
5
2023-07-06
Previously Untreated Metastatic or Unresectable Melanoma
-
2022-501600-10-00
5
2023-02-07
Atrial fibrillation and Chronic Kidney Disease stage 5
-
2022-500618-24-00
6
2022-12-01
prostate cancer, benign prostate hyperplasia
-
2024-514139-50-00
5
2022-11-14
Multiple myeloma
-
2023-504885-50-00
5
2022-11-07
Treatment of children with chronic kidney disease and proteinuria
-
2022-501180-40-00
5
2022-06-17
Ewing Sarcoma